close
read more
Our group
Governance
Global presence
Key figures
History
Vocation, vision and values
Culture
Financial Results
Servier Institute
Our healthcare offering
Servier medicines
Generic medicines
e-Health solutions
Our areas of expertise
Research & Development
Therapeutic areas
Development portfolio
Clinical trials
Regulatory affairs
Pharmacovigilance
Servier Paris-Saclay R&D Institute
Medical promotion
Industry
Industrial quality
Production
Supply Chain
CDMO Services
Medical Affairs
Third-Party Sponsor studies
Business development & licensing
Our commitments
Patient
Ethics
Compliance policy
CSR approach
Fight against counterfeiting
Supplier relationship
Servier endowment fund
Newsroom
News
Press release
Insight
Corporate publishing
Medical publishing
FR
MEDIATOR INFORMATION
NEWS
ROOM
News
Press release
Insight
Corporate publishing
Medical publishing
Monoclonal antibodies: their role and potential
04 / 06 / 2020
Insight
Gastric cancer: a disease of the stomach
06 / 05 / 2020
Insight
Autism: When the brain gets in the way
02 / 04 / 2020
Insight
All about acute lymphoblastic leukemia
10 / 01 / 2020
Insight
Depression, the world’s leading cause of disability
25 / 10 / 2019
Insight
Venous disease: when the circulatory system is affected
17 / 06 / 2019
Insight
Colorectal cancer: screening too late
22 / 05 / 2019
Insight
Understanding the human microbiota: essential microorganisms
21 / 03 / 2019
Insight
Lupus: a rare disease that affects women
28 / 02 / 2019
Insight
Hypertension: a silent killer
10 / 12 / 2018
Insight
The hope of CAR-T, living drugs against cancers
16 / 10 / 2018
Insight
Action on cancer: Servier fighting on three promising fronts
05 / 09 / 2018
Insight